2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC2132
Submitter : Miss. Natalie Ralston Date & Time: 10/31/2005 06:10:25
Organization : Miss. Natalie Ralston
Category : Individual Consumer
Issue Areas/Comments
I oppose the constant delays in making EC available over the counter. Please don't let politics interfere with womens health.